Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to $24.5 million.

  • Agilon Health's Depreciation & Amortization (CF) rose 1949.18% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 2164.3%. This contributed to the annual value of $24.5 million for FY2024, which is 2133.82% up from last year.
  • Latest data reveals that Agilon Health reported Depreciation & Amortization (CF) of $24.5 million as of FY2024, which was up 2133.82% from $20.2 million recorded in FY2023.
  • Agilon Health's Depreciation & Amortization (CF)'s 5-year high stood at $24.5 million during FY2024, with a 5-year trough of $13.8 million in FY2022.
  • For the 5-year period, Agilon Health's Depreciation & Amortization (CF) averaged around $17.4 million, with its median value being $14.7 million (2021).
  • As far as peak fluctuations go, Agilon Health's Depreciation & Amortization (CF) tumbled by 6595.51% in 2020, and later surged by 4639.12% in 2023.
  • Annual analysis of 5 years shows Agilon Health's Depreciation & Amortization (CF) stood at $14.1 million in 2020, then rose by 4.05% to $14.7 million in 2021, then dropped by 6.12% to $13.8 million in 2022, then skyrocketed by 46.39% to $20.2 million in 2023, then rose by 21.34% to $24.5 million in 2024.
  • Its Depreciation & Amortization (CF) was $24.5 million in FY2024, compared to $20.2 million in FY2023 and $13.8 million in FY2022.